Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
AIDS Research and Human Retroviruses|January 12, 2021
Pretreatment HIV Drug Resistance Among Adults Initiating or Re-Initiating First-Line Antiretroviral Therapy in Zimbabwe: Fast-Tracking the Transition to Dolutegravir-Based First-Line Regimens?Vinie Kouamou, Justice Mavetera, Justen Manasa, et al.Journal of Clinical Microbiology|June 12, 2020
Diagnostic Accuracy of Pan-Degenerate Amplification and Adaptation Assay for HIV-1 Drug Resistance Mutation Analysis in Low- and Middle-Income CountriesVinie Kouamou, Justen Manasa, David Katzenstein, et al.Scientific Data|July 25, 2018
Selection analyses of paired HIV-1 gag and gp41 sequences obtained before and after antiretroviral therapyPhilip L Tzou, Soo-Yon Rhee, Sergei L Kosakovsky Pond, et al.AIDS (London, England)|July 31, 2019
Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapyVinie Kouamou, Justen Manasa, David Katzenstein, et al.AIDS Research and Therapy|January 22, 2014
Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohortSureshnee Pillay, Ruth M Bland, Richard J Lessells, et al.AIDS Research and Human Retroviruses|October 29, 2021
HIV-1 Genetic Diversity and Natural Polymorphisms of the Integrase Gene in Integrase Inhibitor-Naive Patients in Harare, ZimbabweAmanda Madyadi, Milcah Dhoro, Tinei Shamu, et al.AIDS Research and Treatment|November 22, 2024
Weight and Lipid Levels in People Living With HIV and Initiating a Dolutegravir-Based Regimen in a Resource Limited Setting: A Prospective StudyRudo Chakanetsa, Raylton P Chikwati, Itai Chitungo, et al.AIDS Research and Human Retroviruses|March 7, 2020
Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line TreatmentVinie Kouamou, Bhavini Varyani, Tinei Shamu, et al.Virology Journal|July 10, 2026
Major protease inhibitor drug resistance mutations among patients with virological failure on second-line antiretroviral therapy in Zimbabwe: a retrospective cross-sectional studyJustin Mayini, Tendai Washaya, Justen Manasa, et al.Health Science Reports|November 12, 2025
Prevalence and Correlates of Hyperglycemia Among People Living With HIV and TB on Dolutegravir-Based Antiretroviral Therapy in Zimbabwe: A Cross-Sectional StudyTafadzwa Zireva, Cuthbert Musarurwa, Arthur Mazhandu, et al.Pageof 7